Peptable

Comparison

BPC-157 vs TB-500

Also see:

BPC-157TB-500

Function

While BPC-157 is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects111, TB-500 is studied for enhancing musculoskeletal and cardiac repair, wound healing, and promoting cell migration and differentiation via actin cytoskeleton remodeling21255.

Mechanism

While BPC-157 works as a synthetic 15-amino-acid fragment of a gastric cytoprotective protein that promotes angiogenesis and tissue protection primarily by modulating VEGFR2 signaling, Src/caveolin-1–dependent eNOS activation, and nitric oxide production111, TB-500 is a synthetic peptide comprising the LKKTETQ actin-binding motif of thymosin beta-4 that binds G-actin, sequesters actin monomers, and promotes cell migration, angiogenesis, and tissue repair1255.

Receptor

BPC-157

VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, with downstream eNOS and nitric-oxide–mediated signaling11

TB-500

Binds monomeric actin (G-actin) rather than a classical cell-surface receptor, modulating actin polymerization at barbed and pointed ends55

Organism or Origin

BPC-157

Synthetic peptide derived from a naturally occurring human gastric 'Body Protection Compound' isolated from human gastric juice111

TB-500

Synthetic derivative of human thymosin beta-4, whose full-length 43-amino-acid protein is abundant in mammalian tissues21279

Gene

BPC-157

Not assigned in the current dataset.

TB-500

TMSB4X

Summary

Both peptides fall into a similar broad context as Signal peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Musculoskeletal health contexts, while BPC-157 is more of a signal peptide and TB-500 is better described as a signal peptide. Both appear to work through Signaling modulator, which is one of the main reasons they can look related despite other differences. Both are synthetic in origin and both are still best understood as being in Preclinical development. Their sequence patterns also diverge, with BPC-157 showing proline-rich features and TB-500 showing protein-mimetic sequence features.

Sources

11BPC-157 - Wikipedia, https://en.wikipedia.org/wiki/BPC-157
2TB-500 (Thymosin Beta-4) | Peptide Biologix, https://peptidebiologix.com/tb-500
12Thymosin Beta-4 vs TB-500 | What to Know in 2024, https://www.peptidesciences.com/peptide-research/thymosin-beta-4-vs-tb-500
79TMSB4X Gene: Function, Research, and Clinical Applications, https://learn.mapmygenome.in/genemap/tmsb4x